Chinook Announces Stock Option Grant
BERLIN, Germany, May 8th, 2019 – Chinook Tyee Industry Limited (“Chinook”) (TSXV: XCX) (FSE: C4T), has granted incentive stock options to purchase up to 1,020,000 common shares of Chinook to its directors, officers, employees, and consultants in Germany, Switzerland and Canada pursuant to its stock option plan, including 655,000 options issued to directors and officers. Each option vests immediately, has an exercise price of $0.15 per share and is valid for a period of one year from the date of issuance.
Chinook Tyee Industry Limited Chinook is a Berlin based investment company with two European subsidiaries, AMP Alternative Medical Products GmbH (AMP Germany) and Mercury Partners & Company plc. AMP Germany plans to import pharmaceutical grade (EU-GMP) cannabis produced by Canadian licensed producers into Germany. AMP Germany, in cooperation with its business partners, will provide EU-GMP audit, logistical, transportation, importation and other related services for the importation of medical cannabis into Germany. Mercury Partners & Company plc is a Malta based investment holding company that invests mainly in German distressed assets. Chinook has 10,217,796 shares outstanding and trades on the TSX Venture Exchange (symbol: “XCX”) and the Frankfurt Stock Exchange (symbol: “C4T”). www.amp-eu.com.
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For further information, please contact:
Canada Mr. Alex Blodgett, Director Tel: +1 (236) 833-1602 Email: email@example.com
Germany Email: firstname.lastname@example.org
Social media links: Twitter, Reddit, LinkedIN
SOURCE Chinook Tyee Industry Limited
Chinook Announces Stock Option Grant
About Cannin: Your Marijuana Stock Experts
Cannin is your #1 trusted resource for marijuana and hemp stock investment opportunities. Our global team of experts evaluates all emerging marijuana and hemp stock investing opportunities. We aggregate hundreds of hours of research and provide tips on the best marijuana and hemp stock investments for 2020.
Use Cannin as your resource for:
- Cannabis and hemp investing news
- Featured cannabis and hemp company analysis
- Comprehensive cannabis and hemp stock reports
Is it too late to invest in marijuana or hemp stocks? No! This is the perfect time to invest.
Market analysts expect the marijuana and hemp industry will have an annual value exceeding $75 Billion in the next decade. The time to invest in marijuana and hemp stocks is now. Are you looking to buy stock in hemp companies or marijuana companies for 2020? Interested in emerging penny hemp stock companies? Looking for the best Canadian marijuana stocks to invest in? We can help.
Predict price movements of marijuana and hemp stocks several hours in advance with our proprietary algorithmic stock trading software.
- +25% Gains in 2020
- +49.8% Gains in 2019
- Backtested since 2012
We’re so confident you’ll love our signals, we’re willing to give you a one-month risk-free trial to see it for yourself.
Profit from the best marijuana stocks – we’ll show you how at cannin.com
Can we start writing exclusively about Hemp-Only companies? These include the following: Charlotte’s Web, GW Pharma, CV Sciences, Canopy Growth, Elixinol, Organigram, GrowLife, Emerald Health, Neptune, Global Hemp Group. Also, please see the attached report with additional hemp only companies with analysis. It’s from last year so the data is not current but worth a look.
Marijuana Stocks, Pot Stocks, Algorithmic Stock Trading, Best Hemp Stocks